Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00275119
What this trial is testing

Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Not applicableStudy completedNCT02028377
What this trial is testing

Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Adenocarcinoma Pancreas
Washington University School of Medicine 25
Testing effectiveness (Phase 2)Study completedNCT00094445
What this trial is testing

Trial of Curcumin in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT07255404
What this trial is testing

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
BioNTech SE 105
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Not applicableStudy completedNCT00918853
What this trial is testing

Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas

Who this might be right for
PancreasAdenocarcinoma
Institut Paoli-Calmettes 156
Not applicableLooking for participantsNCT03637569
What this trial is testing

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

Who this might be right for
Pancreas CancerCholangiocarcinomaGallbladder Cancer
Samsung Medical Center 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04887805
What this trial is testing

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more
City of Hope Medical Center 28
Testing effectiveness (Phase 2)WithdrawnNCT02885727
What this trial is testing

Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)

Who this might be right for
Metastatic Pancreas Cancer
University of Maryland, Baltimore
Very early researchEnded earlyNCT01783054
What this trial is testing

Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma Pancreas
Medical University of South Carolina 2
Testing effectiveness (Phase 2)Looking for participantsNCT07701486
What this trial is testing

More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer, MetastaticPancreas Cancer, Stage IVDuctal Adenocarcinoma of the Pancreas
Theriva Biologics SL 6
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)WithdrawnNCT00005591
What this trial is testing

Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Alabama at Birmingham
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT00059982
What this trial is testing

Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03331562
What this trial is testing

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreas AdenocarcinomaAdvanced Pancreatic Cancer+2 more
Translational Genomics Research Institute 24
Early research (Phase 1)Active Not RecruitingNCT05799274
What this trial is testing

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Healthy VolunteersPancreatic Ductal AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+4 more
Radiopharm Theranostics, Ltd 9
Large-scale testing (Phase 3)Looking for participantsNCT07217717
What this trial is testing

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
SOFIE 200
Not applicableStudy completedNCT04765410
What this trial is testing

The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Carol Davila University of Medicine and Pharmacy 57
Next Page